Erektile Dysfunktion – Abklärung und Therapie

Extended Abstract

Erectile dysfunction: evaluation and treatment


Einhaltung ethischer Richtlinien


P. Maletzki gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.


  1. 1.
    Braun M et al (2000) Epidemiology of erectile dysfunction: results of the ‚Cologne Male Survey‘. Int J Impot Res 12(6):305–311CrossRefPubMedGoogle Scholar
  2. 2.
    Capogrosso P et al (2013) One patient out of four with newly diagnosed erectile dysfunction is a young man – worrisome picture from the everyday clinical practice. J Sex Med 10(7):1833–1841CrossRefPubMedGoogle Scholar
  3. 3.
    Sanda MG et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250–1261CrossRefPubMedGoogle Scholar
  4. 4.
    Sikka SC et al (2013) Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med 10(1):120–129CrossRefPubMedGoogle Scholar
  5. 5.
    Sohn M et al (2013) Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures. J Sex Med 10(1):172–179CrossRefPubMedGoogle Scholar
  6. 6.
    Goldstein I et al (1998) Oral sildenafil in the treatment of erectile dysfunction. J Urol 167(2 Pt 2):1197–1203 (discussion 1204)Google Scholar
  7. 7.
    Curran M et al (2003) Tadalafil. Drugs 63(20):2203–2212 (discussion 2213–2214)CrossRefPubMedGoogle Scholar
  8. 8.
    Chung E et al (2011) A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother 12(8):1341–1348CrossRefPubMedGoogle Scholar
  9. 9.
    Giovanni C et al (2016) The safety and efficacy of Avanafil, a new 2 generation PDE5i: comprehensive review and meta-analysis. Expert Opinion on Drug Safety 15(2):237–247CrossRefGoogle Scholar
  10. 10.
    Goldstein I et al (2012) A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Avanafil in subjects with erectile dysfunction. J Sex Med 9(4):1122–1133PubMedGoogle Scholar
  11. 11.
    Salonia A et al (2012) Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol 62(2):273–286CrossRefPubMedGoogle Scholar
  12. 12.
    Montorsi F et al (2005) Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2(5):658–667CrossRefPubMedGoogle Scholar
  13. 13.
    Brock G et al (2003) Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 170(4 Pt 1):1278–1283CrossRefPubMedGoogle Scholar
  14. 14.
    Montorsi F et al (2004) Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 172(3):1036–1041CrossRefPubMedGoogle Scholar
  15. 15.
    Porst H et al (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10(1):130–171CrossRefPubMedGoogle Scholar
  16. 16.
    Natali A et al (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5(6):1503–1512CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Urologie, EBU Certified Training CentreKantonsspital WinterthurWinterthurSchweiz

Personalised recommendations